Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

View:
Post by stockbuphoon on Jun 19, 2021 11:46pm

Ad hominem

You think that Thomson is a swing day trader like you and is not burying 4050? Guess you made lots of money on the $7 to $4 short over the last week? Thomson  took years to decide on next phase 2 candidate of 4050 as IPF when markets for kidney and liver were huge and results strong - as in "penicillin" as quoted by Laurin and Moran. So, you're saying they lied and Pritchard is telling the truth? Ryplazim? They spent $100's of millions for $70M from PRV and $5M for plasma division which include IVIG and many others. Sure, kid. Can you quote anything from foundational value argument of any analyst? Didn't think so..
Comment by realstocky on Jun 19, 2021 11:51pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities